Board Meeting Details

The Board meeting commenced at 11:00 AM and concluded at 5:30 PM on 29th May 2026.

Key Approvals and Financial Results

1. Audited Financial Statements: The Board approved both Standalone and Consolidated Financial Statements for the quarter and financial year ended 31st March 2026, as recommended by the Audit Committee.

2. Standalone Financial Performance (Year ended March 2026):

  • Total Income: ₹5,341.55 lakhs (Previous year: ₹2,818.48 lakhs)
  • Profit before tax: ₹104.77 lakhs (Previous year: loss of ₹544.55 lakhs)
  • Net Profit: ₹90.99 lakhs (Previous year: loss of ₹390.40 lakhs)
  • Earnings per share (Basic): ₹0.03 (Previous year: loss of ₹0.15)
  • Paid-up equity share capital: ₹26,040.37 lakhs (unchanged)

3. Quarterly Standalone Performance (Q4 March 2026):

  • Total Income: ₹2,103.43 lakhs
  • Profit before tax: ₹640.77 lakhs
  • Net Profit: ₹628.27 lakhs
  • EPS (Basic): ₹0.24

4. Consolidated Financial Performance (Year ended March 2026):

  • Net Loss: ₹996.35 lakhs (Previous year: loss of ₹856.11 lakhs)
  • Total Comprehensive Loss: ₹692.84 lakhs (Previous year: loss of ₹936.11 lakhs)
  • EPS (Basic): loss of ₹0.25 (Previous year: loss of ₹0.26)

5. Security Cover Certificate: Submitted for the quarter and year ended 31st March 2026 pursuant to Regulation 54(3) of SEBI Listing Regulations.

6. Large Corporate Disclosure: Provided as per SEBI circular dated October 19, 2023.

Strategic Corporate Actions

1. Amalgamation Approval: The Board approved in-principle the scheme of amalgamation of PVP Corporate Parks Private Limited (wholly-owned subsidiary) with and into the Company, subject to statutory, regulatory, shareholder and other approvals.

2. Committee Reconstitution: The Board reconstituted various committees (Audit, Nomination & Remuneration, Stakeholders Relationship, and CSR) with effect from 29th May 2026.

Significant Transactions and Investments

1. NCD Issuance: On 11th April 2025, the company allotted 15,000 Secured, Rated, Listed Non-Convertible Debentures of face value ₹1,00,000 each aggregating ₹15,000 lakhs:

  • 9,500 NCDs (Series A) to LICHFL Housing & Infrastructure Fund (₹9,500 lakhs)
  • 5,500 NCDs (Series B) to LICHFL Real Estate Debt Opportunities Fund-I (₹5,500 lakhs)
  • Transaction costs of ₹409.19 lakhs to be amortized over loan tenure
  • NCDs listed on NSE debt platform

2. Acquisition of Optimus Oncology: On 23rd April 2025, approved acquisition of 56% shareholding in Optimus Oncology Private Limited for ₹5,473.66 lakhs, completed in Q1 FY2026.

3. Acquisition of 7Med India: On 4th November 2025, acquired 33.24% stake in 7Med India Private Limited for ₹6,750.19 lakhs, with consolidation from 1st January 2026.

4. Acquisition of Biohygea Global: On 28th November 2024, approved acquisition of 52% stake in Biohygea Global Private Limited (Medilabs) for ₹700 lakhs, completed in Q1 FY2026.

Regulatory and Legal Matters

1. SEBI Investigation: The company received summons from SEBI on 19th March 2025, 8th May 2025, 6th June 2025 and 4th September 2025 under Section 11(2), 11C(2)/(3) of SEBI Act regarding loans and investments to erstwhile subsidiaries PVP Global Ventures, PVP Media Ventures, and Safetrunk Services. The company has responded with documentation. Matter remains under investigation.

2. GST Demand: Received show cause notice from DG GST Intelligence dated 22nd July 2024 demanding ₹687.53 lakhs plus penalty of ₹687.53 lakhs (total ₹1,375.06 lakhs) for North Town Project. The Madras High Court passed favorable order on 21st July 2025, resulting in reversal of provisions during FY2026.

3. Related Party Compliance: The company is assessing compliance with Regulation 23 of Listing Regulations regarding related party transactions, noting that any past non-compliance won't materially impact current financial results.

Subsidiary Updates

1. Safetrunk Services: Voluntarily struck off from ROC on 8th May 2025.

2. NCCPL Loan: Outstanding loan of ₹21,843.49 lakhs to New Cyberabad City Projects Limited (erstwhile subsidiary, now related party) with security of land and development rights. Ongoing litigation with ED and SEBI regarding attached properties, but management believes amounts are fully recoverable.

Segment Information

The Group has three reportable segments: Real Estate, Health Care Services, and Others. For FY2026:

  • Real Estate segment revenue: ₹3,564.08 lakhs
  • Healthcare Services segment revenue: ₹642.26 lakhs (loss)
  • Total segment assets: ₹79,395.28 lakhs
  • Total segment liabilities: ₹38,840.50 lakhs

Auditor Information

CNGSN & Associates LLP appointed as statutory auditors from Q3 FY2026, replacing predecessor auditors PSDY & Associates. Unmodified audit opinion issued on both standalone and consolidated financial results.

Financial Position (Standalone as at 31st March 2026)

  • Total Assets: ₹52,049.65 lakhs
  • Total Equity: ₹21,402.31 lakhs
  • Total Liabilities: ₹30,647.34 lakhs
  • Borrowings: ₹20,598.74 lakhs (Non-current: ₹12,978.15 lakhs, Current: ₹7,620.59 lakhs)

Key Ratios (Standalone)

  • Debt-Equity Ratio: 0.96
  • Current Ratio: 0.62
  • Interest Service Coverage Ratio: 2.47
  • Operating EBITDA Margin: 72.30%
  • Net Profit Margin: 26.48%